Namshik Han
banner
namshik.bsky.social
Namshik Han
@namshik.bsky.social
Cambridge scientist and entrepreneur exploring AI, Quantum, and Drug Discovery. Bridging computation and biomedicine for innovation.
Great team effort! Our new paper is out. 🎉

I am happy to share that our paper on multi-modal network analysis for lung cancer targets has been published in Communications Chemistry and selected for their special Nature Portfolio Collections on Computational methodology for drug discovery.
December 16, 2025 at 6:30 AM
Reposted by Namshik Han
In this interview from @elrig.org’s #DD25, @namshik.bsky.social explains quantum algorithms with a London Tube analogy, how they can be applied to benefit drug discovery and his advice for researchers wanting to launch their own startups >>> www.biotechniques.com/computationa...
Quantum questions have algorithmic answers: navigating a drug discovery network
In this interview, Namshik Han explains the role quantum algorithms can play in drug discovery research and what makes a successful startup.
www.biotechniques.com
November 20, 2025 at 2:24 PM
🚀 From #Apollo to #Quantum!

#IBM Watson Research powered the Apollo Missions, shaped supercomputing, and now leads Quantum Computing. Seeing System Two and discussing Quantum #DrugDiscovery collaborative projects with George Tulevski, Gopal Karemore, and Petra Florizoone was a privilege.
March 18, 2025 at 12:45 PM
A #dozen years at the University of Cambridge! 🎉

From standing solo with a secret agent to now leading a #lab full of real-world scientific agents. What a ride! Honoured to have spent over a decade growing my #career in such an inspiring place.

#Cambridge has been an incredible journey, onward!
February 6, 2025 at 10:19 AM
Reposted by Namshik Han
Utilising multi-modal data-driven network analysis to identify monotherapy and combinational therapy targets in SOX2-dependent squamous cell lung cancer https://www.biorxiv.org/content/10.1101/2025.01.30.635634v1
February 5, 2025 at 6:47 AM
Reposted by Namshik Han
Utilising multi-modal data-driven network analysis to identify monotherapy and combinational therapy targets in SOX2-dependent squamous cell lung cancer https://www.biorxiv.org/content/10.1101/2025.01.30.635634v1
February 5, 2025 at 6:47 AM
🚀 Big news! Our first use of #quantum algorithms in #AI network-based #DrugDiscovery is a success!

We applied #QuantumWalk-based analysis to explore #LongCOVID, identifying novel targets and pathways. A new era for our lab begins!
doi.org/10.48550/arX...

#QuantumAI #Biotech
February 5, 2025 at 11:03 AM
🚀 New Preprint Alert!

Our research shows how #AI #MultiModal #NetworkAnalysis identifies #Monotherapy & #CombinationalTherapy targets for SOX2-driven lung cancer.

A scalable & validated approach for broader disease applications!

🔗 doi.org/10.1101/2025...

#DrugDiscovery #MultiOmics
February 5, 2025 at 11:02 AM